Net profit of Indraprastha Medical Corporation rose 57.11% to Rs 31.17 crore in the quarter ended March 2024 as against Rs 19.84 crore during the previous quarter ended March 2023. Sales rose 14.84% to Rs 314.73 crore in the quarter ended March 2024 as against Rs 274.05 crore during the previous quarter ended March 2023.For the full year,net profit rose 43.89% to Rs 123.96 crore in the year ended March 2024 as against Rs 86.15 crore during the previous year ended March 2023. Sales rose 13.29% to Rs 1244.70 crore in the year ended March 2024 as against Rs 1098.67 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales314.73274.05 15 1244.701098.67 13 OPM %15.3912.09 -15.5313.72 - PBDT51.7737.06 40 206.19156.45 32 PBT41.5627.20 53 166.11117.18 42 NP31.1719.84 57 123.9686.15 44 Powered by Capital Market - Live News

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News

Indraprastha Medical Corporation has received reaffirmation in credit rating from ICRA as under:a) long-term credit rating of ICRA AA and short-term rating of ICRA A1+ for Rs. 62.50 crore bank facilities; and b) short-term credit rating of ICRA A1+ for Rs. 40.0 crore Commercial Paper. Powered by Capital Market - Live News

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 7 March 2024.Powered by Capital Market - Live News

Indraprastha Medical Corporation announced the resignation of Udit Prakash Rai (DIN: 07573658) as director of the company on 04 August 2023. Powered by Capital Market - Live News